AzTrials
AzTrials

Bone LossNCT05261334

Socket Shield Technique Versus Early Implant Placement With Contour Augmentation

A study testing contour augmentation in people with Bone Loss and Bone Resorption, run by Iman Abd-ElWahab Radi, PhD at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

comparing socket shield technique with early implant placement with contour augmentation in preserving the bone contour Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Bone Loss, Bone Resorption
What is being tested?
contour augmentation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
31 Mar 2022to 1 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Non-restorable maxillary teeth in the esthetic zone
  • Intact adjacent teeth
  • Adequate palatal and apical bone that allows achieving implant primary stability.
  • Type I socket
  • ≥18 years
  • ≤ 60 years
  • Systemically healthy patients

Who cannot join

  • Extraction sockets with acute or chronic infection or with adjacent infected teeth
  • Heavy Smokers > than 10 cigarettes daily
  • Cancer patients undergoing radiotherapy or chemotherapy during or within the last 6 months.
  • Unmotivated patients to maintain adequate oral hygiene to follow up.
  • Patients with physical disabilities that could affect follow up.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Cairo, 11553

    iman abdelwahab radi, PHD, 01001539613 ext. 002, iman.abdelwahab@dentistry.cu.edu.eg

    Amir alaa Elawady, BDS, 01020205791, Amir112093@miuegypt.edu.eg

Other trials in Egypt

About this study

Official title: Socket Shielding in Immediate Versus Early Implant Placement With Contour Augmentation of Fresh Extraction Sockets in the Esthetic Zone. A Randomized Pilot Clinical Study.

comparing socket shield technique with early implant placement with contour augmentation in preserving the bone contour

Read the detailed description

comparing immediate implant placement with socket shield technique and final crown after 3 months with extraction and after 4 to 8 weeks implant placement with contour bone augmentation then after 3 to 4 months final crown delivery

Being tested
contour augmentation
Medical subject headings
Bone Diseases, Metabolic, Bone Resorption

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • contour augmentationProcedure or surgery

    early implant placement with contour bone augmentation

Study groups in NCT05261334
Study groupRoleWhat they receive
socket shield techniqueActive comparatorimmediate implant placement with socket shield technique
Receives: Procedure: contour augmentation
contour augmentationActive comparatorearly implant placement with contour bone augmentation
Receives: Procedure: contour augmentation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. facial bone thickness

    using superimposed CBCT images

    Measured: 12 months

Secondary outcomes (2)
  1. facial bone height changes

    using superimposed CBCT images

    Measured: 12 months

  2. Soft tissue height changes

    using superimposed intraoral scans

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2022
  2. Study start31 Mar 2022 (estimated)
  3. Primary completion31 Mar 2023 (estimated)
  4. Study completion1 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05261334
Sponsor's protocol ID
sst versus contour aug
Status last verified
Mar 2022
First submitted
28 Jan 2022
Last updated
25 Mar 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing contour augmentation in people with Bone Loss and Bone Resorption, run by Iman Abd-ElWahab Radi, PhD at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

facial bone thickness (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in